This year, the Maryland Stem Cell Research Fund will disburse $8.2 million in grants and loans to promote state-funded stem cell research and cures. The MSCRF supports technologies at all stages of development from discovery to commercialization.

To be considered, researchers, innovators and entrepreneurs must submit applications by Thursday, Jan. 18. Here are programs currently accepting applications and their requirements:

This program supports research grants designed to aid investigators working on new and innovative hypotheses, approaches, mechanisms or models that may differ from current thinking in the stem cell field and have no preliminary data supporting the application.

Grants awarded under this request for application (RFA) will fund basic and translational research involving human stem cells.

The Validation Program is designed to foster the transition of promising stem cell technologies from universities and research labs to the commercial sector to be developed into products and services.

This program fosters the commercialization of such technologies through technology validation, market assessment and the creation of university startups in Maryland. Additionally, the program aims to build collaborations between various schools, departments and institutions.

Note: To be considered for this program, you must have disclosed your technology to Johns Hopkins Technology Ventures by Dec. 8, 2017.

Designed to create startups from promising technologies with significant commercial potential, this program supports the development of products and services that meet identified market needs.

Specifically, the Commercialization Program fosters the commercialization of such technologies through technology validation, market assessment and the creation of university startups in Maryland.

Note: To be considered for this program, the Maryland startup applying must have licensed a technology from Johns Hopkins Technology Ventures within 90 days of award.

Questions? Please email Hannah Jannarone (hdj@jhu.edu).

Share This Post